Published in Biomed Pharmacother on August 28, 2006
Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal (2009) 3.19
Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol Metab (2010) 2.53
Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell (2007) 2.14
Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev (2009) 1.88
Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl Recept Signal (2009) 1.80
Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell (2009) 1.77
p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2). J Biol Chem (2012) 1.55
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal (2008) 1.47
The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process. EMBO J (2010) 1.39
Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet (2009) 1.32
Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol Cell Biol (2008) 1.30
Androgen receptor signaling and mutations in prostate cancer. Asian J Androl (2010) 1.27
Metformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity. Diabetes (2011) 1.16
Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy. Nucleic Acids Res (2011) 1.09
Kinases and protein phosphorylation as regulators of steroid hormone action. Nucl Recept Signal (2007) 1.04
The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. Mol Endocrinol (2010) 1.01
Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1. Mol Cell Biol (2011) 1.00
Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity. Mol Endocrinol (2009) 1.00
Genome stability roles of SUMO-targeted ubiquitin ligases. DNA Repair (Amst) (2009) 1.00
Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase. Mol Endocrinol (2011) 0.99
Detection of proteins sumoylated in vivo and in vitro. Methods Mol Biol (2009) 0.98
Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1). Mol Cell Biol (2008) 0.98
Progesterone receptor isoform functions in normal breast development and breast cancer. Crit Rev Eukaryot Gene Expr (2008) 0.97
Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity. Oncogene (2010) 0.95
Structural and functional analysis of domains of the progesterone receptor. Mol Cell Endocrinol (2011) 0.95
Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation. Oncogene (2013) 0.94
Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation. BMC Mol Biol (2012) 0.94
Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion. Mol Cell Endocrinol (2012) 0.93
Dynamics of coactivator recruitment and chromatin modifications during nuclear receptor mediated transcription. Mol Cell Endocrinol (2007) 0.93
Nicotinamide uncouples hormone-dependent chromatin remodeling from transcription complex assembly. Mol Cell Biol (2007) 0.93
The AR dependent cell cycle: mechanisms and cancer relevance. Mol Cell Endocrinol (2011) 0.93
Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: circadian rhythm-associated alterations of glucocorticoid actions in target tissues. Mol Cell Endocrinol (2010) 0.92
Tracking progesterone receptor-mediated actions in breast cancer. Pharmacol Ther (2013) 0.91
Acquisition of sexual receptivity: roles of chromatin acetylation, estrogen receptor-alpha, and ovarian hormones. Endocrinology (2011) 0.90
Post-translational modifications of the progesterone receptors. J Steroid Biochem Mol Biol (2013) 0.88
Estrogens, Neuroinflammation, and Neurodegeneration. Endocr Rev (2016) 0.87
Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation. Biologics (2008) 0.87
Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies? J Biomed Biotechnol (2010) 0.86
Estrogen receptor-beta and breast cancer: translating biology into clinical practice. Steroids (2012) 0.84
Binding of the ERalpha nuclear receptor to DNA is coupled to proton uptake. Biochemistry (2010) 0.84
Synergistic Action of Flavonoids, Baicalein, and Daidzein in Estrogenic and Neuroprotective Effects: A Development of Potential Health Products and Therapeutic Drugs against Alzheimer's Disease. Evid Based Complement Alternat Med (2013) 0.82
Age-related differences in cardiac ischemia-reperfusion injury: effects of estrogen deficiency. Pflugers Arch (2013) 0.81
MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies. ISRN Hematol (2013) 0.80
Resveratrol stimulates cortisol biosynthesis by activating SIRT-dependent deacetylation of P450scc. Endocrinology (2012) 0.80
Seasonal changes in androgen receptor mRNA in the brain of the white-crowned sparrow. Gen Comp Endocrinol (2009) 0.80
Proteomic analysis of the androgen receptor via MS-compatible purification of biotinylated protein on streptavidin resin. Proteomics (2011) 0.79
Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells. PLoS One (2013) 0.79
New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer. Prostate Cancer (2011) 0.79
TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth. Oncotarget (2016) 0.76
Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies. Expert Opin Ther Targets (2016) 0.76
Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling? Curr Pharmacogenomics Person Med (2008) 0.75
Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors. J Biol Chem (2017) 0.75
U2 RNA shares a structural domain with U1, U4, and U5 RNAs. EMBO J (1982) 4.68
Complementary DNA for human T-cell cyclophilin. EMBO J (1987) 2.82
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J (1987) 2.23
A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem (1991) 1.52
High evolutionary conservation of the secondary structure and of certain nucleotide sequences of U5 RNA. Nucleic Acids Res (1983) 1.17
The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3. Eur J Biochem (1996) 1.16
Triabin, a highly potent exosite inhibitor of thrombin. J Biol Chem (1995) 1.14
Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology (1991) 1.13
Primary structure and properties of helothermine, a peptide toxin that blocks ryanodine receptors. Biophys J (1995) 1.12
New androgen response elements in the murine pem promoter mediate selective transactivation. Mol Endocrinol (2001) 1.04
An inhibitor of collagen-induced platelet aggregation from the saliva of Triatoma pallidipennis. J Biol Chem (1994) 1.03
Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes. J Biol Chem (1999) 0.98
CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol Cell Biol (1996) 0.93
Mouse androgen-dependent epididymal glycoprotein CRISP-1 (DE/AEG): isolation, biochemical characterization, and expression in recombinant form. Mol Reprod Dev (1995) 0.91
A family of small nucleoplasmic RNAs with common structural features. Biol Cell (1984) 0.90
Involvement of the N-terminal part of cyclophilin B in the interaction with specific Jurkat T-cell binding sites. Biochem J (1996) 0.90
Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid. Gene (1993) 0.88
The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression. Gene (1991) 0.85
Two 5S genes are expressed in chicken somatic cells. Nucleic Acids Res (1983) 0.81
Isolation and characterization of the androgen-dependent mouse cysteine-rich secretory protein-1 (CRISP-1) gene. Biochem J (1997) 0.81
Mutational analysis of human endothelin receptors ETA and ETB identification of regions involved in the selectivity for endothelin 3 or cyclo-(D-Trp-D-Asp-Pro-D-Val-Leu). Eur J Biochem (1994) 0.80
Isolation and characterization of the androgen-dependent mouse cysteine-rich secretory protein-3 (CRISP-3) gene. Biochem J (1995) 0.80
Stable expression of human endothelin receptors ETA and ETB by transfected baby hamster kidney cells. Biochem Biophys Res Commun (1993) 0.79
Delineation of the calcineurin-interacting region of cyclophilin B. Protein Sci (2000) 0.77
Gene expression during the implantation window: microarray analysis of human endometrial samples. Ernst Schering Res Found Workshop (2005) 0.76
Plasminogen activators from the saliva of Desmodus rotundus (common vampire bat): unique fibrin specificity. Ann N Y Acad Sci (1992) 0.76
Pharmacology and clinical use of sex steroid hormone receptor modulators. Handb Exp Pharmacol (2012) 0.76
The antiprogestin Lonaprisan inhibits breast cancer cell proliferation by inducing p21 expression. Mol Cell Endocrinol (2010) 0.76
Binding characteristics of recombinant human endothelin receptors ETA and ETB expressed in baby hamster kidney cells. J Cardiovasc Pharmacol (1993) 0.75
High-level secretion of the four salivary plasminogen activators from the vampire bat Desmodus rotundus by stably transfected baby hamster kidney cells. Gene (1992) 0.75
Evaluation of the 5'-flanking regions of murine glutathione peroxidase five and cysteine-rich secretory protein-1 genes for directing transgene expression in mouse epididymis. Biol Reprod (2001) 0.75